These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25062880)

  • 1. Abnormal distribution of peripheral lymphocyte subsets induced by PDAC modulates overall survival.
    Xu YF; Lu Y; Cheng H; Shi S; Xu J; Long J; Liu L; Liu C; Yu X
    Pancreatology; 2014; 14(4):295-301. PubMed ID: 25062880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil-lymphocyte ratio (NLR) was associated with prognosis and immunomodulatory in patients with pancreatic ductal adenocarcinoma (PDAC).
    Xiang ZJ; Hu T; Wang Y; Wang H; Xu L; Cui N
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32510138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reference ranges of lymphocyte subsets in healthy adults and adolescents with special mention of T cell maturation subsets in adults of South Florida.
    Valiathan R; Deeb K; Diamante M; Ashman M; Sachdeva N; Asthana D
    Immunobiology; 2014 Jul; 219(7):487-96. PubMed ID: 24661720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating regulatory T cell subsets predict overall survival of patients with unresectable pancreatic cancer.
    Liu C; Cheng H; Luo G; Lu Y; Jin K; Guo M; Ni Q; Yu X
    Int J Oncol; 2017 Aug; 51(2):686-694. PubMed ID: 28714519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infiltrating immune cells and gene mutations in pancreatic ductal adenocarcinoma.
    Wang WQ; Liu L; Xu HX; Wu CT; Xiang JF; Xu J; Liu C; Long J; Ni QX; Yu XJ
    Br J Surg; 2016 Aug; 103(9):1189-99. PubMed ID: 27256393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
    Distler M; Pilarsky E; Kersting S; Grützmann R
    Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating CD4+CD25+ regulatory T cells in patients with pancreatic cancer.
    Yamamoto T; Yanagimoto H; Satoi S; Toyokawa H; Hirooka S; Yamaki S; Yui R; Yamao J; Kim S; Kwon AH
    Pancreas; 2012 Apr; 41(3):409-15. PubMed ID: 22158072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative Neutrophil-Lymphocyte and Lymphocyte-Monocyte Ratios Reflect Immune Cell Population Rearrangement in Resectable Pancreatic Cancer.
    Sierzega M; Lenart M; Rutkowska M; Surman M; Mytar B; Matyja A; Siedlar M; Kulig J
    Ann Surg Oncol; 2017 Mar; 24(3):808-815. PubMed ID: 27770341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
    JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic significance of peripheral T-lymphocyte subsets and natural killer cells in patients with colorectal cancer.
    Qiu H; Xiao-Jun W; Zhi-Wei Z; Gong C; Guo-Qiang W; Li-Yi Z; Yuan-Fang L; Rajiv-Prasad K
    Hepatogastroenterology; 2009; 56(94-95):1310-5. PubMed ID: 19950782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes of lymphocyte subsets in peripheral blood of patients with hepatitis C].
    Wan H; Li Y; Yang N; Yuan W; Xie N; Wang D; Guo T; Mao Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1058-61. PubMed ID: 25270208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring and functional characterization of the lymphocytic compartment in pancreatic ductal adenocarcinoma patients.
    Oberg HH; Grage-Griebenow E; Adam-Klages S; Jerg E; Peipp M; Kellner C; Petrick D; Gonnermann D; Freitag-Wolf S; Röcken C; Sebens T; Vogel I; Becker T; Ebsen M; Kabelitz D; Wesch D; Sebens S
    Pancreatology; 2016; 16(6):1069-1079. PubMed ID: 27424476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effects of Treatment on Peripheral Blood Immune Cell Profile in Pancreatic Ductal Adenocarcinoma (PDAC).
    Tulyte S; Characiejus D; Matuzeviciene R; Janiulioniene A; Radzevicius M; Zvirblis T; Sileikis A
    Anticancer Res; 2022 Jun; 42(6):3067-3073. PubMed ID: 35641268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of circulating T-lymphocyte subsets in advanced pancreatic cancer patients treated with mFOLFIRINOX or gemcitabine.
    Tulyte S; Characiejus D; Matuzeviciene R; Janiulioniene A; Radzevicius M; Jasiunaite E; Zvirblis T; Sileikis A
    Int Immunopharmacol; 2023 Feb; 115():109722. PubMed ID: 37724957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating lymphocyte subsets in pancreatic adenocarcinoma and their relationship to the stage of the disease.
    Pezzilli R; Fabbri D; Imbrogno A; Morselli-Labate AM; Corinaldesi R
    Pancreas; 2012 Aug; 41(6):976-8. PubMed ID: 22781914
    [No Abstract]   [Full Text] [Related]  

  • 16. Intraepithelial Attack Rather than Intratumorally Infiltration of CD8+T Lymphocytes is a Favorable Prognostic Indicator in Pancreatic Ductal Adenocarcinoma.
    Zhang J; Wang YF; Wu B; Zhong ZX; Wang KX; Yang LQ; Wang YQ; Li YQ; Gao J; Li ZS
    Curr Mol Med; 2017; 17(10):689-698. PubMed ID: 29521231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of age, gender and lifestyle in lymphocyte subsets: report from the Spanish Gait-2 Study.
    García-Dabrio MC; Pujol-Moix N; Martinez-Perez A; Fontcuberta J; Souto JC; Soria JM; Nomdedéu JF
    Acta Haematol; 2012; 127(4):244-9. PubMed ID: 22538526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative abnormalities of peripheral blood distinct T, B, and natural killer cell subsets and clinical findings in obstetric antiphospholipid syndrome.
    Carbone J; Gallego A; Lanio N; Navarro J; Orera M; Aguaron A; Fernandez-Cruz E; Sarmiento E
    J Rheumatol; 2009 Jun; 36(6):1217-25. PubMed ID: 19332638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features.
    D'Arena G; Musto P; Cascavilla N; Di Giorgio G; Fusilli S; Zendoli F; Carotenuto M
    Haematologica; 1998 Mar; 83(3):197-203. PubMed ID: 9573672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral lymphocyte populations in ovarian cancer patients and correlations with clinicopathological features.
    Ye S; Chen W; Zheng Y; Wu Y; Xiang L; Li T; Ping B; Zhang X; Yang H
    J Ovarian Res; 2022 Apr; 15(1):43. PubMed ID: 35410290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.